AlphaYouTP
Insider selling
Terrance P. Coyne sold $3.5M of Royalty Pharma plc (RPRX) stock
Terrance P. Coyne, EVP & CFO of Royalty Pharma plc (RPRX), sold 64,399 shares of RPRX stock worth $3.5M, per an SEC Form 4 filed May 28, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on May 26, 2026, 2 days before it was made public.
RPRX has moved +8.5% since the trade date, from $53.86 to $58.44 (Sep 21, 2026 close).
- Traded
- May 26, 2026
- Disclosed
- May 28, 2026
- Filing delay
- 2 days
- Price since
- +8.5%
- Role
- EVP & CFO
- Source
- SEC Form 4
More RPRX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.